Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GLAS · against 273 other Healthcare companies of similar size
Ranked #192 of 274 · scores higher than 30% of peers · safety percentile 33
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)29 peers with a safety percentile of 30–39, including GLAS · Click a bar to see the companies
Mainly because of its current ratio, beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GLAS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 246 reported | 0.44× | 0.21× | 31% | 33% | |
| BetaLower is better · 261 reported | 0.77 | 0.52 | 34% | 33% | |
| Current ratioHigher is better · 270 reported | 1.33× | 3.06× | 21% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 165M USD | 99 | 50 | |
| 4 | 261M USD | 99 | 97 | |
| 5 | 397M USD | 99 | 37 | |
| 188 | 1.6B HKD (≈$209M) | 33 | 44 | |
| 189 | 2.0B CNY (≈$284M) | 33 | 34 | |
| 190 | 471M NZD (≈$282M) | 33 | 23 | |
| 191 | 26.5B INR (≈$317M) | 33 | 34 | |
| 192 | 221M USD | 33 | 33 | |
| 193 | 3.0B CNY (≈$427M) | 33 | 36 | |
| 194 | 3.1B HKD (≈$396M) | 32 | 61 | |
| 195 | 35.2B JPY (≈$240M) | 31 | 12 | |
| 196 | 354M USD | 31 | 13 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score